Sign in Subscribe
COVID-19

Trump's Shift on Vaccines: A Laissez-Faire Approach

Strategic Insights

— 2 min read

As the COVID-19 pandemic rages on, President Trump's stance on vaccines has undergone a significant shift. In the spring of 2020, he was warned by medical officials that developing a vaccine could take over a year, but he demanded a faster program, leading to the creation of Operation Warp Speed. This initiative resulted in lifesaving vaccines containing messenger RNA (mRNA), widely regarded as the quickest way to protect Americans against future threats. However, time seems to have marched on, and President Trump has now shrugged off the announcement of cutting $500 million in grants and contracts for mRNA vaccine research.

Key Takeaways:

  • President Trump has shifted his stance on vaccines, abandoning his previous support for mRNA vaccines after coming into office.
  • The administration has cut $500 million in grants and contracts for mRNA vaccine research, with Health and Human Services Secretary Robert F. Kennedy Jr. citing reduced funding for "other answers to other problems, to other sicknesses and diseases."
  • Mr. Trump's willingness to give Mr. Kennedy space to impose his views is notable, given that the vaccines were once seen as a legacy achievement during Mr. Trump's first term.
  • The president's laissez-faire approach has raised concerns among critics, who believe the administration's other pursuits should not come at the expense of working on vaccines that saved millions of lives.
  • Senator Bill Cassidy, a Republican from Louisiana and a physician who voted to confirm Mr. Kennedy, stated that the decision to take away the funding threatened to undermine Mr. Trump's agenda, writing on social media that it "works against both of President Trump's goals."
  • Admiral Brett Giroir, an assistant health secretary in the first Trump administration, recalled that the president had been "very pro-vaccine" and had signed an executive order in 2019 calling for the modernization of flu vaccines.

Some notable critics of the Trump administration's vaccine policies, including Robert F. Kennedy Jr. and Senator Bill Cassidy, have expressed concern about the impact on public health. Dr. Robert F. Kennedy Jr. has spoken about the need for alternative solutions and has questioned the efficacy of mRNA vaccines, while Senator Cassidy has warned that this decision undermines the president's agenda.

Statistics:

  • $500 million: The amount of grants and contracts for mRNA vaccine research cut by the Trump administration.
  • 17: The number of committee members at the Centers for Disease Control and Prevention (CDC) that were fired under Robert F. Kennedy Jr.'s leadership.
  • 2019: The year in which President Trump signed an executive order calling for the modernization of flu vaccines.

Sources:

  • The New York Times article by Maggie Haberman, Kenneth P. Vogel, and Katie Thomas, "Trump Administration Scales Back Vaccine Research, Focusing on New Initiatives", September 11, 2022.
  • The New York Times article by Maggie Haberman, Kenneth P. Vogel, and Katie Thomas, "Trump's Shift on Vaccines: A Laissez-Faire Approach", September 9, 2022.
  • Department of Health and Human Services release, "Updated information on COVID-19 vaccine development".

Read more